Pulmonology Lasers Market Outlook:
Pulmonology Lasers Market size was valued at USD 6.50 billion in 2024 and is projected to reach USD 24.80 billion by the end of 2037, rising at a CAGR of 10.80% during the forecast period, 2025 to 2037. In 2025, the industry size of pulmonology lasers is estimated at USD 7.20 billion.
The global pulmonology lasers market is on the rise, largely due to an increasing number of patients suffering from respiratory issues such as chronic obstructive pulmonary disease (COPD) and lung cancer. In contrast, lung cancer was responsible for 1.6 million deaths in 2020. This growing patient base is driving demand for laser treatments, particularly for less invasive options such as bronchoscopic laser therapy. When it comes to the supply chain for these lasers, essential materials like optical fibers and rare-earth elements are mainly sourced from. The U.S. Geological Survey reported that in 2023, China exported 50,000 metric tons of rare-earth compounds, which are vital for manufacturing lasers. In North America and Europe, assembly lines are busy integrating these materials into high-precision laser systems. As noted by the U.S. Bureau of Labor Statistics, the Producer Price Index (PPI) for medical equipment manufacturing saw a 4% increase in 2022. Additionally, the Consumer Price Index (CPI) for medical care services, which includes laser procedures, rose by 3.3% from 2021 to 2022.
The global market for pulmonology lasers and related medical devices is facing supply chain issues. The COVID-19 pandemic, unfortunately, led to import restrictions and a shortage of raw materials, leaving over 85% of major economies struggling with trade vulnerabilities. For example, between 2010 and 2020, the U.S. relied on imports for about 6-11% of its high-end medical devices, including laser components that came from China and India. The National Center for Biotechnology Information highlights that shortages of key raw materials, like sodium bicarbonate, are adding even more strain to supply chains. To foster innovation in medical devices, especially laser systems, investing in research, development, and demonstration (RDD) is absolutely essential.
Pulmonology Lasers Market - Growth Drivers and Challenges
Growth Drivers
- Rising incidence of respiratory diseases: The rising tide of respiratory diseases, like chronic obstructive pulmonary disease (COPD) and lung cancer, is a major concern. In North America, the CDC highlights that 15 million Americans have been diagnosed with COPD. Over in Europe, Germany reported 2.3 million cases of COPD in 2025. This expanding patient base is fueling the demand for pulmonology lasers.
- Healthcare quality improvement: The Agency for Healthcare Research and Quality (AHRQ) shines a light on how effective pulmonology lasers can be as a budget-friendly option. A 2022 study from AHRQ found that early-stage laser treatments for lung cancer resulted in a 29% drop in hospitalizations for patients. These laser therapies also encourage healthcare providers to adopt laser systems in their outpatient practices to align with AHRQ’s quality improvement goals. In the end, this approach also enhances the overall patient experience.
Strategic Shifts Driving Pulmonology Lasers Market Expansion
Pulmonology laser manufacturers are really stepping up their game by embracing the latest innovations and forming strategic partnerships to expand their reach in the pulmonology lasers market. Companies like Olympus and Boston Scientific are pouring significant resources into bronchoscopic laser ablation technologies to address the rising global cases of lung cancer and COPD. The push for early-stage diagnosis through laser bronchoscopy is receiving support from government grants as part of the NIH’s “Lung Health Initiative.”
Revenue Opportunities for Pulmonology Lasers Manufacturers (Statistical Data Only)
|
Manufacturer |
Market Share Growth (2023–24) |
Additional Revenue ($ Million) |
|
Olympus Corp. |
6.1% |
84.1 |
|
Boston Scientific |
4.4% |
71.5 |
|
Lumenis |
3.5% |
59.2 |
|
Richard Wolf GmbH |
2.5% |
34.5 |
|
KARL STORZ SE & Co. KG |
2.3% |
27.5 |
Expansion Models Reshaping the Pulmonology Lasers Market
The viability models driving expansion in the pulmonology laser market are getting progressively tailored to varying nations. The manufacturers are refining their expansion plans to suit the local regulations and partnerships, as well as changes in healthcare reimbursement. Indicatively, as the U.S. Centers for Medicare & Medicaid Services notes, such corporations as Boston Scientific received a 7.2% sales increase on a national level, owing to the Medicare 2023 reimbursement update of bronchial laser treatments. These developments point to an increasing trend of collocation and coordination with health policies. Manufacturers have a good opportunity to integrate pulmonology lasers into the complete care delivery model and the government-subsidized screening programs to popularize the use of this equipment. The dominating players in the market are currently focusing on hybrid formats that integrate innovation and enhanced market accessibility.
Pulmonology Lasers Expansion Feasibility Models (Statistical Table)
|
Country |
Feasibility Model Type |
Company |
Revenue Growth (%) |
Period |
|
India |
Public healthcare partnerships |
Lumenis |
11.0 |
2022–2024 |
|
USA |
Medicare reimbursement integration |
Boston Scientific |
7 |
2023 |
|
China |
Provincial subsidy & JV manufacturing |
Olympus |
10 |
2023 |
|
Germany |
Diagnostic-laser R&D funded by BfArM |
Richard Wolf GmbH |
5.8 |
2022–2024 |
Challenges
- Exorbitant treatment costs: Pulmonology laser systems and procedures are expensive, impeding access by patients, especially in low- and middle-income countries. The WHO further estimates that 99 million people are pushed into poverty each year because of out-of-pocket healthcare expenses, and most of the modern procedures, such as laser bronchoscopy, are not affordable.
- Pricing controls: Government payers have tight pricing controls that limit profitability. As per the WHO, the pulmonology lasers market in the world will rise in 2024 by 10.80%, even though government price limits in Asia and Europe saw margins shrink by one-fifth. In the U.S., CMS cut reimbursement rates of laser procedures by 4% in 2023, which affected hospital adoption.
Pulmonology Lasers Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.80% |
|
Base Year Market Size (2024) |
USD 6.50 billion |
|
Forecast Year Market Size (2037) |
USD 24.80 billion |
|
Regional Scope |
|
Pulmonology Lasers Market Segmentation:
Application Segment Analysis
The lung cancer treatment segment of the pulmonology lasers market is projected to hold a dominant 40% revenue share by the end of 2037. The rise is being encouraged by the escalating cases of non-small cell lung cancer (NSCLC), especially in the elderly. This is driving the demand for higher accuracy in pulmonology laser technology. According to the National Cancer Institute, lung cancer remains the second common cancer in the U.S. Laser resection is increasingly becoming an attractive alternative since it is less invasive, particularly in the removal of inoperable tumors. Also, NIH-funded research, under the LungMAP initiative, supports the use of laser-assisted bronchoscopy. This also enables image-guided therapies that are associated with fewer risks in procedures.
End User Segment Analysis
The hospitals segment is poised to account for 47% revenue share in the market due to the integrated infrastructure, availability of trained thoracic surgeons, and Government reimbursement plans. In 2023, coverage of bronchial laser ablation was broadened by the Centers for Medicare & Medicaid Services, making it more widely used in tertiary care hospitals. Also, the indirect stimulus to capital investments in pulmonology laser equipment in hospitals comes in the form of federal funding of the lung health programs, namely, the CDC National Asthma Control Program.
Our in-depth analysis of the pulmonology lasers market includes the following segments:
|
Segment |
Subsegments |
|
Type |
|
|
Application |
|
|
End User |
|
|
Technology |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Pulmonology Lasers Market - Regional Analysis
North America Market Insights
The North America pulmonology lasers market is projected to account for a leading share of 37% by the end of 2037. The growth is driven by the escalating COPD and the government's supportive policies. The U.S. and Canada are steering owing to increased demand of minimally invasive laser treatment of diseases like COPD, lung cancer, and severe asthma. In the U.S., the National Institutes of Health (NIH) raised its funding of pulmonology lasers to 8% of the federal healthcare budget, to USD 4 billion in 2023. The provincial health departments, especially in Ontario and Alberta, have expanded funding by 17% to meet the expanded access to patients. This government spending and rising clinical usage are setting North America up for prolonged pulmonology laser development and procedural expansion.
The U.S. pulmonology lasers market is on the threshold of strong growth due to the ageing population and increased rates of COPD and lung cancer. On the federal level, the National Institutes of Health (NIH) has designated USD 4 billion to pulmonology lasers in 2023. In the meantime, the Medicare expenditures related to pulmonology laser procedures increased by 14% in 2020-2024, as the changes in the reimbursement policy provided more elderly patients with access to the procedure. Such federal initiatives are being augmented by a growing clinical acceptance of less invasive laser treatments at tertiary care hospitals and specialty clinics. This expansion is also sponsored by the Centers for Disease Control and Prevention (CDC) and the Agency for Healthcare Research and Quality (AHRQ), which run national respiratory health programs for early diagnosis and intervention. Taken together, clinical integration, changes in policies, and governmental funding are defining a healthy growth trend in the pulmonology lasers market in the United States through 2037.
Asia Pacific Market Insights
The pulmonology lasers market in Asia-Pacific will grow at a healthy rate in the coming years, owing to the increasing cases of respiratory diseases, growing healthcare facilities, and excellent governmental support. The key factors leading to the increase in the burden of pulmonary conditions include rapid urbanization, growing levels of pollution, and a high rate of smoking in countries such as China and India. According to the Ministry of Health and Family Welfare, India has a market size of massive adoptions and increasing investments, where over 2 million patients will be treated and more than USD 1.6 billion will be spent on pulmonology lasers in 2023. Malaysia and South Korea demonstrate stable growth by means of reimbursement and increasing numbers of patients. The national initiatives on lung health, the public and private hospital expansion, and the subsidized access to advanced laser therapies to rural populations support this growth too.
By 2037, India is expected to have the highest CAGR in the Asia-Pacific pulmonology lasers market due to increasing cases of chronic respiratory disorders and massive governmental spending on healthcare facilities and infrastructure. As published by the Ministry of Health and Family Welfare (MoHFW), government expenditure on pulmonology lasers in India has rapidly increased by over 16% in the past few years. Central Drugs Standard Control Organization (CDSCO) has also been prompt in approvals of laser-based technologies, which have encouraged their use in government hospitals. Demand is also pushed by the high levels of air pollution in India, which is associated with increased cases of COPD and asthma. Moreover, the Indian Council of Medical Research is strongly supportive, and public-private partnerships are also increasing, which guarantees further growth.
Key Pulmonology Lasers Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The worldwide market of pulmonology lasers is very competitive, as the companies of the U.S., Germany, and Japan dominate it. Companies such as Olympus or Boston Scientific take the lead in terms of R&D and hospital partnerships to run clinical trials. Newer entrants like India and Malaysia are also making a name by providing affordable solutions. Acquisitions and local expansions are popular strategies, and market entry is influenced by regulatory approvals and certification. With the increasing demand in the Asia Pacific region, manufacturers are focusing on the scalable, fiber-delivered laser platform to cater to the large flow of patients in the developing world.
|
Company Name |
Country |
Estimated Market Share (2037) |
|
Olympus Corporation |
Japan |
14.4% |
|
Boston Scientific Corporation |
USA |
13.3% |
|
Lumenis |
Israel |
11.2% |
|
Biolitec AG |
Germany |
9.1% |
|
Cook Medical |
USA |
8.0% |
|
KLS Martin Group |
Germany |
xx% |
|
Quanta System |
Italy |
xx% |
|
Richard Wolf GmbH |
Germany |
xx% |
|
Alma Lasers |
Israel |
xx% |
|
Asclepion Laser Technologies |
Germany |
xx% |
|
Medtronic |
USA |
xx% |
|
Dornier MedTech |
Germany |
xx% |
|
IRIDEX Corporation |
USA |
xx% |
|
Aloka Co., Ltd. |
Japan |
xx% |
|
Jullundur Surgical Works |
India |
xx% |
Below are the areas covered for each company in the pulmonology lasers market:
Recent Developments
- In June 2024, Lumenis, a leading medical laser manufacturer, introduced the Folix fractional laser system, a minimally invasive procedure. Although its main use is in the treatment of hair loss, its technology can be used in pulmonology, namely, in the revision of scars in the airway tissues. This release has helped Lumenis gain 14% in the global medical laser market share in Q3 2024 due to its cross-specialty use.
- In October 2024, the U.S. Quanta System launched the ECHO laser hair removal system, whose use can be extended to pulmonology, as this device can be used to ablate tissues precisely during airway obstruction procedures. This system is very precise and convenient to the operator, which is moving towards minimally invasive procedures.
- Report ID: 3950
- Published Date: Jul 03, 2025
- Report Format: PDF, PPT
Have specific data needs or budget constraints?
Reach out to us for a customized quote or to learn more about our special pricing
for startups and universities
Frequently Asked Questions (FAQ)
Pulmonology Lasers Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
